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sustained cellular responses, including cell growth and proliferation. However, it has not been clarified how the same receptor
mediates such opposing effects. To address this question, we have combined electrophysiological, imaging, and mathematical
studies using wild-type and mutant rat P2X7Rs. Activation of naı¨ve (not previously stimulated) receptors by low agonist concen-
trations caused monophasic slow desensitizing currents and internalization of receptors without other changes in the cellular
morphology, much like other P2XRs. In contrast, saturating agonist concentrations induced high-amplitude biphasic currents,
reflecting pore dilation and causing rapid cell swelling and lysis. The existence of these two signaling patterns was accounted
for using a revised Markov-state model that included, in addition to naı¨ve and sensitized states, desensitized states. Occupancy
of one or two ATP-binding sites of naı¨ve receptors favored a slow transition to desensitized states, whereas occupancy of the
third binding site favored a transition to sensitized/dilated states. Consistent with model predictions, nondilating P2X7R mutants
always generated desensitizing currents. These results suggest that the level of saturation of the ligand binding sites determines
the nature of the P2X7R gating and cellular actions.INTRODUCTIONThe purinergic P2X7 receptor channel (P2X7R) is a multi-
functional protein. It forms a cation-permeable channel
that is activated within tens of milliseconds after application
of agonists. This is followed by a gradual (second to minute
timescales) increase in permeability to large organic cations
and fluorescent dyes, leading to collapse of Naþ and Kþ gra-
dients, excessive Ca2þ influx, and ultimately cell death.
These observations have provided a base for the hypothesis
that pore formation is cytolytic (1–3). Other researchers
have reported delayed P2X7R-mediated cell death by
apoptosis through caspase-dependent and/or -independent
pathways (4,5). Paradoxically, P2X7R also promotes
serum-independent cell growth, an action incompatible
with cell-death signaling (6,7). Activated receptors also
regulate multiple types of plasma membrane (PM) composi-
tion and trafficking responses, including shedding of surface
proteins and blebbing, and intracellular membrane traffic
and organelle function (8). Activation of multiple intracel-
lular signaling pathways, usually associated with sti-
mulation of G-protein-coupled receptors, has also been
reported for P2X7Rs (9), as has activation of nonclassical
secretion pathways (8). However, it has not been clarified
how the same receptor triggers multiple signaling pathways
and cellular responses and what the relationship is between
P2X7R gating and receptor functions.
Earlier studies have suggested the presence of two steps
in P2X7R activation: opening of the channel pore followed
by pore dilation, a process that could cause cell lysis bySubmitted February 11, 2013, and accepted for publication May 2, 2013.
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including fluorescent dyes (10). More conclusive evidence
for P2X7R pore dilation was obtained in experiments with
naı¨ve receptors (not previously exposed to ATP) (11). These
experiments showed generation of a rapid current response
accompanied by secondary current growth during sustained
agonist application, which temporally coincided with the
development of conductivity to larger organic cations. The
same study also showed the loss of biphasic response in
several N- and C-terminal mutants that were instantaneously
permeable to larger organic cations. North and colleagues
also showed recently that P2X7R channels allow direct
permeation of nanometer-size dyes (12). Furthermore, Sur-
peprenant et al. (13) and our group (14) showed that a tran-
sition from naı¨ve to sensitized/facilitated states occurs in
receptors during repetitive agonist application. A Markov-
state model consisting of naı¨ve and sensitized states was
also developed to capture the kinetics of P2X7R (14) and
study the influence of bath Ca2þ on the gating properties
of these receptors (15).
However, the concentration-dependence studies revealed
the existence of small-amplitude monophasic currents
induced by lower agonist concentrations. Furthermore, the
Markov model predicted that the occupancy of two binding
sites on naı¨ve receptors (i.e., receptors residing in the naı¨ve
state) was sufficient for channel pore opening, whereas oc-
cupancy of the third binding site was required for dilation
(14). These results prompted us to examine in more detail,
and experimentally as well as theoretically, the transition
from partial to full occupancy of ligand-binding sites. Elec-
trophysiological experiments were done with rat wild-type
(WT) receptors and mutant receptors that do not exhibithttp://dx.doi.org/10.1016/j.bpj.2013.05.006
Desensitization in P2X7 Receptors 2613pore dilation. The focus of these studies was the pattern of
P2X7R currents at low and high agonist concentrations
during sustained agonist application at receptors in the
naı¨ve state. To study morphological changes in cell
structure caused by two patterns of signaling, we also
used an enhanced-yellow-fluorescent-protein (EYFP)-
tagged P2X7 construct and an enhanced-cyan-fluorescent-
protein (pECFP)-endoplasmic reticulum (ER) marker
construct and confocal imaging. Finally, we revised our
eight-state Markov model by including four additional
states representing Ca2þ-independent desensitization of
P2X7R, previously described for P2X2R (16). The main
conclusion reached in this study was that partial occupancy
of ATP-binding sites leads to receptor desensitization asso-
ciated with cell-life signaling, whereas occupancy of the
third binding site triggers pore dilation associated with the
cell-death signaling pathway.MATERIALS AND METHODS
Cell culture
HEK293 and GT1 cells were used for the expression of various P2X7R con-
structs, as described previously (17). HEK293 cells (obtained from Amer-
ican Type Culture Collection; Manassas, VA) were routinely maintained in
Dulbecco’s modified Eagle’s medium (D-MEM) containing 10% (v/v) fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1% (v/v) penicillin-strepto-
mycin liquid (Invitrogen) in a tissue-culture incubator. GT1-7 cells (pro-
vided by R.I. Weiner, University of California, San Francisco, San
Francisco, CA) were cultured in Dulbecco’s modified Eagle’s medium/
Ham’s F-12 medium (1:1) containing 10% (vol/vol) fetal bovine serum
and 100 mg/ml gentamicin (Invitrogen). Cells were grown on 35-mm dishes
at a density of 0.5  106 cells/dish for electrophysiological measurements
and on 25-mm coverslips at 0.15  106 cells per dish for imaging studies.
Transfection was conducted 24 h after plating the cells using 2 mg of DNA
and 5 ml of lipofectamine 2000 reagent (Invitrogen) in 2 ml of serum-free
Opti-MEM. After 4.5 h of incubation, the transfection mixture was replaced
with normal culture medium and cells were cultured for an additional
24–48 h. For electrophysiological measurements, transfected cells were
mechanically dispersed and recultured on 35-mm dishes of Corning 3294
CellBIND Surface (Corning, NY) for 2–8 h before recording.Transfection and constructs
The rat P2X7-pIRES2-EGFP construct (18) was used for generation of
other constructs. The C-terminal EYFP-tagged P2X7 construct was gener-
ated by deleting sequences between the C-terminus of coding sequences of
subcloned P2X7 cDNA and the initiation codon of the EYFP gene of the
Clontech (Mountain View, CA) pEYFP-N1 vector. Deletion was created us-
ing the QuikChange XL site-directed mutagenesis kit (Stratagene, La Jolla,
CA) according to the manufacturer’s instructions. The pECFP-ER marker
construct was made by inserting the oligo sequence of the 17-amino-acid
ER targeting sequence of calreticulin with Nhe I-Age I cutting at the 50
end of the ECFP gene of the Clontech pECFP-N1 vector, inserting the
ER retrieval sequence KDEL at the 30 end, and removing the Kozak
sequence of the pECFP-N1 vector through the QuikChange XL site-
directed mutagenesis reaction, as developed previously (17,19). The
mutagenic oligonucleotide primers were synthesized, and purified by poly-
acrylamide gel electrophoresis (PAGE; Integrated DNATechnology, Coral-
ville, IA). Production of the correct constructs was verified by dye
terminator-cycle sequencing (performed by Macrogen USA, Rockville,MD). Large-scale plasmid DNAs were prepared using a QIAfilter Plasmid
Maxi kit (Qiagen, Valencia, CA).Current measurements
Whole-cell patch-clamp recordings were done using single cells at room
temperature and an Axopatch 200B amplifier (Axon Instruments, Union
City, CA), as described previously (19). Patch electrodes, fabricated from
borosilicate glass (type 1B150F-3; World Precision Instruments, Sarasota,
FL) using a Flaming Brown horizontal puller (P-97, Sutter Instruments, No-
vato, CA), were heat-polished to a final tip resistance of 3.5 to 5.0 MOhm.
All current records were programmed, captured, and stored using the
pClamp 8.0 software packages in conjunction with the Digidata 1322A
A/D converter (Axon Instruments). Experiments were done on single cells
with an average capacitance of 10 pF. Unless otherwise stated, membrane
potential was held at 60 mV. Patch electrodes were filled with solution
containing 145 mM NaCl, 10 mM EGTA, and 10 mM HEPES; the pH
was adjusted to 7.35 with 10 M NaOH. The osmolarity of this solution
was 293 mOsM. The regular Krebs-Ringer-like (KR) bath buffer contained
147 mMNaCl, 3 mMKCl, 1 mMMgCl2, 2 mMCaCl2, 10 mM glucose, and
10 mM HEPES; the pH was adjusted to 7.35 with 10 M NaOH. All the
buffers with 10 mM HEPES contain additional 2.8 mM Naþ, which origi-
nates from the NaOH pH-adjusted 1 M HEPES stock solution (Mediatech,
Manassas, VA). The osmolarity of these solutions was 289–295 mOsM. The
ATP and BzATP solution was prepared daily in bath buffer with pH prop-
erly readjusted; it was applied using either an Ultrafast Solution-Switching
System (LSS-3200, EXFO Burleigh Products Group, Victor, NY) that was
simultaneously program-controlled by pClamp 8.0 software through a PZ-
150M Amplifier (17) or an RSC-200 Rapid Solution Changer (Biologic-
SAS, Claix, France) (11). Cells with EGFP fluorescence were identified
before immersing the electrode in bath solution for gigaohm seal.Imaging studies
Imaging was performed with a Zeiss LSM 510 inverted scanning confocal
microscope (Carl Zeiss MicroImaging, Thornwood, NY). CFP and YFP
were successively excited by the 405-nm line from a solid-state laser and
the 514-nm line from an argon ion laser, respectively. Emission filters
used were LP420 and BP530-600. An objective lens with 63 magnifica-
tion was used with a further 2 zoom applied. During the sustained agonist
stimulation of P2X7R-expressing cells, there was significant loss of YFP
signals and a smaller loss of CFP signals in the membrane region due to
bleaching, receptor internalization, PM blebbing, and cell swelling. To
show qualitative changes in the cell during stimulation more clearly, we
enhanced contrast in individual images (ImageJ, National Institutes of
Health, Bethesda, MD). This process had no effect on the images taken
in the early stages of stimulation, but was more pronounced in later stages.
Agonist was added either by pipette or by a perifusion system when agonist
washout was necessary. In the latter case, a peristaltic pump (Minipuls 3,
Gilson, Middleton, WI) was used at the rate of 1 ml/min.Mathematical model
We previously developed (14) a Markov-state model that described
agonist binding and unbinding to P2X7R, consisting of four naı¨ve states
not previously exposed to agonist stimulation, C1, C2, Q1, and Q2 (Fig. 1,
middle row), and four sensitized states, C3, C4, Q3, and Q4 (Fig. 1, lower
row). The model was extended here by including four additional Ca2þ-in-
dependent desensitized states, Di, i ¼ 1; 2; 3; 4 (Fig. 1, upper row). Each
state represents the fraction of receptors that are either naı¨ve, sensitized,
or desensitized, with a given number of agonist-binding sites occupied
(Fig. 1, solid circles). The states Ci;Di are closed, whereas the states
Qi, are open, i ¼ 1; 2; 3; 4. The conductance of the open states Q1;Q2Biophysical Journal 104(12) 2612–2621
FIGURE 1 The scheme for the revised P2X7R Markov-state model. The
two lower rows are the same as the original eight-state model published pre-
viously (14), with the middle row representing receptors in the naı¨ve states
and the lower row representing receptors in the sensitized states. The four
additional states in the upper row correspond to Ca2þ-independent desensi-
tization as previously modeled for P2X2R (16). Open circles indicate sites
unoccupied by ligands and solid circles indicate ligand-occupied sites. Re-
ceptors in states Ci and Di have closed channel pores, whereas receptors in
the Qi states, have open channel pores i ¼ 1; 2; 3; 4. Parameter values,
including forward, backward, and transition rates, are listed in Table 1.
2614 Khadra et al.is assumed to be smaller than the conductance of the dilated states
Q3;Q4, i.e., g12<g34. The transitions between naı¨ve and sensitized states
are dictated by both 1), ~30-min requirement for receptor recovery; and
2), allowance for a small rate of reversibility in the dilation process (14).
To reflect negative cooperativity in agonist binding (where binding affin-
ity decreases as each site is occupied) in the naı¨ve and desensitized
states, forward rates k2, k4, and k6 and backward rates k1, k3, and k5
were assumed to satisfy k6=ð3k5Þ<k4=k3<3k2=k1. The Markov model
was not constrained to obey detailed balance, because we assumed that
the forward and backward transitions are realized with the consumption
of an external source of energy provided by either ATP or phosphoryla-
tion (20).
According to the above description and Fig. 1, the revised mathematical
model describing P2X7R gating is given by
dD1
dt
¼ k1D2  ð3k2Aþ H1ÞD1 (1)
dD2
dt
¼ 3k2AD1 þ 2k3D3 þ H2C2  ðk1 þ 2k4Aþ H3ÞD2
(2)
dD3
dt
¼ 2k4AD2 þ 3k5D4 þ bH2Q1  ð2k3 þ k6AÞQ1 (3)
dD4
dt
¼ k6AD3 þ H2Q2  3k5D4 (4)
dC1
dt
¼ H1D1 þ k1C2 þ L1C4  3k2AC1 (5)Biophysical Journal 104(12) 2612–2621dC2
dt
¼ H3D2 þ 3k2AC1 þ 2k3Q1  ðk1 þ 2k4Aþ H2ÞC2
(6)
dQ1 ¼ 2k AC þ 3k Q  2k þ k Aþ bH Q (7)
dt
4 2 5 2 3 6 2 1
dQ2
dt
¼ k6AQ1 þ L2Q3  ð3k5 þ L3 þ H2ÞQ2 (8)
dC4 ¼ k C  ðL þ 3k AÞC (9)
dt
1 3 1 2 4
dC3 ¼ 3k AC þ 2k Q  ðk þ 2k AÞC (10)
dt
2 4 1 4 1 2 3
dQ4 ¼ 2k AC þ 3k Q  ð2k þ k AÞQ (11)
dt
2 3 1 3 1 2 4
dQ3 ¼ k AQ þ L Q  ð3k þ L ÞQ ; (12)
dt
2 4 3 2 1 2 3
where A is the applied agonist concentration, Li are the rates of sensitiza-
tion/loss of sensitization, and Hi; bH2, i ¼ 1; 2; 3, are the rates of desensiti-
zation/loss of desensitization. The equations are fit to data with BzATP to
keep model parameters consistent with those of the original model (14);
nonetheless, the results are congruent with ATP-associated data. The allo-
steric regulation of P2X7R by divalent cations modeled in Yan et al. (15)
was neglected here because of the extracellular concentrations of divalent
cations, [DC]e, used in the experiments.
Based on the above description, the whole-cell current is given by
I ¼ g12ðQ1 þ Q2ÞðV EÞ þ g34ðQ3 þ Q4ÞðV EÞ; (13)
where V is the holding potential and E is the reversal potential. Table 1 lists
all parameter values and the distributions used to generate random values of
these parameters when simulating heterogeneous population of cells.
The model is deterministic and fit to data on whole-cell currents. It does
not attempt to capture the flickering seen in single-channel recordings, nor
does it address the apparent delay between ATP binding and channel open-
ing (21), as this is very rapid (<1 s) and would be averaged out in whole-
cell current recordings taken over minutes.
Parameter values were estimated using either the time constants of the
current (L1, k2/k1, k4/k3, and k6/k5) or by applying ad hoc fitting based
on the kinetics of these receptors (L2, L3). The use of systematic approaches
for parameter estimation remains to be done. Whenever possible, model
simulations and current recordings were shown side by side to ease
comparison.RESULTS
Monophasic currents and receptor
desensitization and internalization
Current recordings and imaging studies were done in single
cells expressing rat P2X7Rs and bathed in KR-like buffer
containing 2 mMCa2þ. Because the P2X7R sensitizes/facil-
itates during repetitive agonist application (13,14), we stud-
ied the effects of ATP and BzATP on the pattern of current
response and morphological changes only in cells with
TABLE 1 Parameter values and distributions used in the
simulations
Symbol
Parameter values and distributions
Value Distribution
k1 0.3 s
1 Normal, s ¼ 0.03
k2 40,000 (M.s)
1 Normal, s ¼ 4000
k3 2.4 s
1 Normal, s ¼ 0.24
k4 50,000 (M.s)
1 Normal, s ¼ 5000
k5 1.58 s
1 Normal, s ¼ 0.158
k6 7000 (M.s)
1 Normal, s ¼ 700
L1 0.0001 s
1
L2 0.004 s
1 Normal, s ¼ 0.001
L3 0.5 s
1 Normal, m ¼ 1a, s ¼ 0.5
H1 0.001 s
1
H2 0.01 s
1 Normal, s ¼ 0.001
H^2 0.01, 0.8
b s1 Normal, s ¼ 0.001
H3 0, 1
b s1
g12 (Q1 þ Q2 conductance) 1.5  108 S Normal, s ¼ 1.5  109
g34 (Q3 þ Q4 conductance) 4.5108 S Normal, s ¼ 4.5  109
V (holding potential) 0.06 V
E (reversal potential) 0 V
aThe mean is not the same as the default value (needed to increase hetero-
geneity in Fig. S4).
bThese values are only used to produce Fig. 6 B (to generate the cusp).
Desensitization in P2X7 Receptors 2615naı¨ve receptors, if not otherwise specified. To minimize the
effects of applying agonists on the pattern of current
response, in all experiments, agonists were added using an
ultrafast solution-switching system with a resolution time
of ~1 ms (see Materials and Methods). When stimulated
with lower agonist concentrations (3.2 mM BzATP or
320 mM ATP), P2X7R generated a monophasic current,
with peak amplitude ranging between 10 and 100 pA. Dur-
ing sustained agonist application, the secondary current
growth typically observed in cells stimulated with high
agonist concentration was not seen. Rather, we observed a
monoexponential decay in the current, indicating that recep-
tors slowly desensitize under these experimental conditions
(Fig. 2 A). Slow desensitization was also observed in cells
bathed in Ca2þ-deficient KR buffer (data not shown), indi-
cating further that P2X7R desensitization occurs in a
Ca2þ-independent manner.
Fig. 2 B, left, shows that 24 h after transfection of GT1-7
cells, the YFP-tagged P2X7R was expressed in the PM of
the cell body and axon, as well as in the cytosol, but not
in the nucleus. The level of cytosolic localization of the
receptor varied among the cells, and it decreased with exten-
sion of the posttransfection period. As expected, the CFP-
labeled ER marker calreticulin was expressed in the cytosol
but not in the PM or nucleus (Fig. 2 B, middle). The overlap-
ping of the two images confirmed that the cytosolic P2X7R
was localized in the ER (Fig. 2 B, right), and the transient
nature of this localization was consistent with the de novo
synthesis of this receptor after the transfection. Imaging
experiments also revealed that double-transfected cells
responded to 3.2 mM BzATP with limited internalizationof receptors after several minutes of stimulation (Fig. 2C,
arrowheads), slightly affecting peak amplitude and decay
phase of the current (or desensitization). On the other
hand, PM and ER structures were not affected and PM bleb-
bing was not observed. The volume of cells did not change
considerably during stimulation, and there was no cell lysis
at any time point during sustained or repetitive agonist
application.Biphasic currents and cell lysis
We showed previously that biphasic currents in naı¨ve cells
are regularly observed in response to application of BzATP
and ATP in the 10–100 mM and 0.5–5 mM concentration
ranges, respectively. These currents were composed of early
fast (I1) and sustained slow (I2) current components (14). At
100 mM BzATP concentration, the plateau in the I2 current
was reached during 20–70 s of agonist application (Fig. 3 A,
left), with peak amplitudes of I1 and I2 equal to 2.35 0.4 nA
and 4.2 5 0.5 nA, respectively. During sustained agonist
application, recording of the whole-cell current was
frequently limited to 3–20 min, because of loss of giga
seal (Fig. 3 A, right). When application of agonist was
limited to 40 s, followed by 4- to 5-min washout periods,
loss of giga seal was also observed after five to eight
applications.
Imaging studies provided an explanation for the loss
of giga seal in electrophysiological studies. Development
of biphasic currents was always associated with major
morphological changes, with the rates of change in PM
and ER structures dependent on agonist concentration.
Fig. 3 B shows the effects of sustained application
of 100 mM BzATP on the morphology of differentiated
GT1-7 cells. The BzATP-induced morphological changes
were present in all three compartments: cell body, axon,
and growth cone. There was an increase in the volume
of the cell body and growth cone, along with vacuolization
and destruction of the axon, culminating in lysis of the
cells (Fig. 3 B). Changes in the volume of the cells were
accompanied by fragmentation and vesiculation of the ER
(Fig. 3 C).Modeling of P2X7R gating
As described in detail in Materials and Methods and Fig. 1,
the revised P2X7R Markov-state model incorporates the
original eight-state model published previously (14), con-
sisting of naı¨ve (middle row) and sensitized states (lower
row), augmented with four additional states representing
desensitization (upper row). These four states were added
to describe Ca2þ-independent desensitization in a manner
similar to what was previously done for P2X2R (16). In
contrast to P2X2R, the inclusion of states representing
bath-Ca2þ-dependent P2X7R desensitization was notBiophysical Journal 104(12) 2612–2621
FIGURE 2 Slow-desensitizing monophasic P2X7R currents and morphological changes induced by low agonist concentrations. (A) Representative traces
of currents in response to 3.2 mMBzATP and 320 mMATP. Gray traces indicate experimental records and black lines the fitting curves. t is the time constant
derived frommonoexponential fitting. In this and the following figures, the current responses to initial agonist application (naı¨ve cells) are shown. (B) Expres-
sion of YFP-tagged P2X7R (left) and CFP-tagged calreticulin sequence (middle) 24 h after transfection. The overlap (right) indicates that P2X7R was still
present in the ER of the lower cell. Note the synaptic-like connection between the two cells and the presence of P2X7R in the axon. (C) Internalization of
P2X7R induced by monophasic currents in a cell stimulated with 3.2 mMBzATP. At this agonist concentration, prolonged exposure to agonist never induced
other morphological changes. For better visibility, YFP fluorescence is shown in green and CFP fluorescence in red in these and the following images. Yellow
arrowheads point to internalized receptors. In this and the following figures, electrophysiological experiments were performed in HEK293 cells and imaging
studies were done in GT1-7 cells expressing rat P2X7R.
2616 Khadra et al.necessary, because desensitization was not facilitated in the
presence of Ca2þ.
We initially tested the ability of the new model to
simulate various aspects of P2X7R gating. Fig. S1 in the
Supporting Material shows that model simulations of con-
centration-dependent effects of BzATP on P2X7R biphasic
currents are highly comparable to those observed with the
original eight-state model (14). However, the new simula-
tions show not only the presence of monophasic current at
low agonist concentrations, but also the decay in current
amplitude after I1 current developed in response to applica-
tion of 3.2 mMBzATP. Sensitization and memory of P2X7R
observed in experiments and reproduced in the original
model (14) were also preserved in the revised P2X7R
model.
Fig. S2, A–C, summarizes simulations of the progressive
increase in the peak amplitude of current response (left)
accompanied by slowing of the rate of receptor deactivation
during repetitive agonist application at the indicated agonistBiophysical Journal 104(12) 2612–2621concentrations with 2-min washout periods (right). In fact,
as shown in Fig. S2 B (left), the new model was more suc-
cessful than the original model in capturing the slowing
down of deactivation during washout periods due to the
progressive loss of receptors to the desensitized states
(Fig. 1, upper row) with repetitive stimulation. Fig. S2 D
shows a simulation of I1 and I1 þ I2 current development
during long and short agonist application (left) and the dif-
ference in the corresponding current decays (right). Fig. S2
E illustrates a progressive increase in the peak current
amplitude during repetitive 1-s agonist applications (left),
accompanied by a slower decay of current after washout
of agonist (right). Fig. S2 F shows the transition from
biphasic to monophasic signaling after sensitization of re-
ceptors by an initial pulse of 320 mM BzATP. Finally, in
Fig. S3, we show the temporal profiles of [Ca2þ]i during
agonist applications at concentrations of 32 mM (gray)
and 320 mM (black). In both cases, the profiles mimic the
activation phase of the current simulations by exhibiting
FIGURE 3 Rapidly developing biphasic currents and morphological changes induced by 100 mM BzATP. (A) Representative traces of biphasic currents
during sustained agonist application. Under these experimental conditions, the peak amplitude of the current was reached within 60 s of stimulation and loss
of giga seal frequently occurred after prolonged recording. (B) Expression of P2X7R in the PM of the cell body, nerve extensions, and growth cones (green
labeling). Development of biphasic current was accompanied by changes in all three compartments. (C) Fragmentation and vesiculation of the ER. The
numbers below the images indicate the duration of 100-mM BzATP application. Note the temporal relationship between generation of high-amplitude
biphasic currents and morphological changes in the PM and ER structures.
Desensitization in P2X7 Receptors 2617slow and fast components in a manner similar to that previ-
ously observed (14, 22). Thus, the new model preserves all
the features exhibited by the original model and captures the
slowing down of deactivation not previously seen.
To summarize the outcomes of these simulations, we
considered in Fig. S4 a heterogeneous population of 10
model cells, generated from the distributions listed in Table
1. Fig. S4 A displays the dose-response curves of the
maximum current amplitude, Im (black line), and current
plateau, Iplateau, evaluated at the end of each agonist applica-
tion (gray line), using increasing concentrations of BzATP
(3.2, 10, 32, 100, and 320 mM). At high doses of BzATP,
the difference between I and Iplateau is negligible, because
sensitization is dominant, unlike at intermediate doses,
where we see a slight right shift in the value of EC50 in favor
of Iplateau due to desensitization. Although the difference
between Im and Iplateau at low BzATP appears negligible in
Fig. S4 A, Fig. S4 B shows that the percent of desensitized
receptors, evaluated using the quantity (Im  Iplateau)/Im, is
also elevated at low doses. The dose-response curve in
this case is a decreasing function of agonist concentration
due to the increase of the dominance of dilation in this
case (i.e., the dominance of L3 over H2 ¼ bH2).Model simulations of desensitization, including the minor
effect of receptor internalization on current decay and
amplitude, in response to prolonged (10-min) application
of 3.2 mM BzATP and 320 mM BzATP are shown in
Fig. 4, A and B, respectively. The contributions of the
open Q1 þ Q2 (black lines) and dilated Q3 þ Q4 (gray lines)
states to P2X7R current, using the same BzATP-stimulation
protocols described in Fig. 4, A and B, are also shown in
Fig. 4, C and D, respectively. In agreement with the data
in Figs. 2 A and 3 A, and as expected from the simulations
in Fig. S4, Fig. 4, A and B, shows that desensitization is
more pronounced at low doses of BzATP than at high doses.
The weak level of stimulation exerted by 3.2 mM BzATP
was insufficient for receptors to shift to the open Q1 þ Q2
and dilated Q3 þ Q4 states (Fig. 4 C) due to the negative co-
operativity in agonist binding assumed in the model (see
also Fig. 2 A); instead, receptors escaped to the upper row
of Fig. 1, causing a decline in Q1 þ Q2 (Fig. 4 C, black
line) and a decrease in current amplitude (Fig. 4 A). At
high BzATP concentration, on the other hand, there was
no apparent decline in current amplitude in the first few sec-
onds, because dilation initially masked desensitization.
Once the peak was reached, the current decayed slowlyBiophysical Journal 104(12) 2612–2621
FIGURE 4 Model simulations of desensitization
and the contributions of open (Q1 þ Q2) and dilated
(Q3 þ Q4) states to P2X7R current during 10-min
application of 3.2 and 320 mM BzATP. (A and B)
Current profiles. (C and D) Simulations of the
open states (Q1þQ2) (black lines) and dilated states
(Q3 þ Q4) (gray lines). The decay of 3.2-mM
BzATP-induced current from the peak (A) was
due to loss of receptors from naı¨ve states to desen-
sitized states (C), whereas the decay of 320-mM
BzATP-induced current (B) was due to a slow leak
of receptors from the dilated state, Q3, back to the
desensitized state, D4, via the open state, Q2 (D).
2618 Khadra et al.(Fig. 4 B) due to a slow leak of receptors from Q3 back
through Q2 to D4 (Fig. 4 D). These results demonstrate
that dilation and desensitization are two competing pro-
cesses regulating P2X7R gating during prolonged stimula-
tion, with the former more apparent at high doses of
BzATP and the latter more apparent at intermediate and
low doses. The same two processes are active in P2X2R,
but there desensitization dominates (16).
To further examine desensitization and the masking effect
in P2X7R, the dilation process in the model was blocked by
setting L3 ¼ 0 (i.e., by excluding the lower row of Fig. 1).
Using this approach, it was possible to simulate receptor
desensitization and the dependence of its rate on agonist
concentration in the absence of dilation. Fig. 5 A shows
that the rate of desensitization in the model increases with
agonist concentration, reaching saturation at 100 mM
BzATP. The nonzero steady-state level of current resultsFIGURE 5 Mathematical (A) and experimental (B–D) characterization of th
Receptor sensitization is excluded from the model by setting L3 ¼ 0 (i.e., by blo
centration. The rate of desensitization is greater at higher agonist concentratio
Y40A- and Y40F-P2X7R mutants show no secondary current growth but relati
model simulations shown in A. (C and D) In cells bathed in Krebs-Ringer buffe
expressing wild-type (WT) receptors, but not in cells expressing the Y40F-P2X7
the ramp protocol (C) and positive shifts in reversal potential (D). The Y40A-P
Biophysical Journal 104(12) 2612–2621mainly from the recovery of some receptors from the desen-
sitized state (Fig. 1, upper row) to the naı¨ve state (Fig. 1,
middle row) during washout. The model thus predicts that
P2X7R desensitizes in a dose-dependent manner, but dila-
tion conceals this process, particularly at high doses.Receptor desensitization and sensitization are
independent processes
The model was built on the hypothesis that receptor desen-
sitization and sensitization are two independent steps in
P2X7R gating, i.e., that channels in the open state can
desensitize or sensitize when all three binding sites are
occupied. In a search for experimental confirmation of this
hypothesis, we screened our library of rat P2X7R mutants.
Among them, the Y40A and Y40F-P2X7R mutants re-
sponded with monophasic desensitizing currents whene kinetics of P2X7R desensitization in nondilating mutant P2X7Rs. (A)
cking dilation) to unveil the dependence of desensitization on BzATP con-
n, when sensitization is prevented. (B) At high agonist concentration, the
vely rapid desensitization, with the kinetics similar to that observed in the
r with NMDG substitution for sodium, pore dilation was observed in cells
R mutant, as illustrated by the time course of agonist-induced currents under
2X7R also does not dilate (data not shown).
Desensitization in P2X7 Receptors 2619stimulated with supramaximal BzATP concentration (Fig. 5
B). Consistent with the model prediction (Fig. 5 A), mutant
P2X7Rs desensitized faster, with a tdes of 15–20 s (Fig. 5 B).
Experiments with cells bathed in KR buffer with N-methyl-
D-glucamine (NMDGþ) substitution for sodium further re-
vealed that there was no pore dilation in the Y40F-P2X7R
mutant, as illustrated by the time course of agonist-induced
currents under the ramp protocol (Fig. 5 C, lower) and pos-
itive shifts in reversal potential (Fig. 5 D, lower), in contrast
to the WT receptor (Fig. 5, C and D, upper). (We did not
model recordings in NMDGþ-only-containing medium
here, but we showed previously for P2X2R (16) that this
could be accounted for by varying the reversal potential of
the open and dilated states in the presence of NMDGþ.)
The Y40A mutant also did not dilate (data not shown).
These experiments suggest that P2X7R desensitizes at
high agonist concentrations, but that the desensitization is
masked by receptor sensitization and transition from the
open to the dilated state.
Consistent with this conclusion, we observed in some re-
cordings the existence of two phases in current growth dur-
ing sustained stimulation with higher agonist concentration.
More specifically, a cusplike response at the start of the sec-
ond phase, I2, was observed in ~40% of cases with cells
stimulated with 1 mM ATP, unmasking a transient decay
of current before the secondary current growth was devel-
oped (Fig. 6 A). The model also generated this cusp
when two parameters of the model were adjusted tobH2 ¼ 0:8 s1 and H3 ¼ 1 s1 (Fig. 6 B), that is, when desen-
sitization and recovery were made faster. This adds to the
evidence that desensitization is an intrinsic property of these
receptors that is generally slow and masked by dilation, but
may surface in some cases when desensitization recovery
rates are faster.DISCUSSION
In whole-cell recording, the majority of P2XRs bathed in
physiological ion conditions respond to agonist stimulation
with amplitude-modulated currents, which could be
described by four parameters: activation time, or time
needed to reach peak amplitude of current (I1 current);
peak current amplitude; desensitization rate, or rate of decayof current amplitude during sustained receptor stimulation;
and deactivation rate, or rate of decay of current amplitude
during washout of agonist. For the majority of P2XRs, the
activation time decreases with increase in agonist concentra-
tion, and the peak current amplitude and rates of receptor
desensitization increase with elevation in agonist concentra-
tion, but the rates of P2XR current deactivation are indepen-
dent of agonist concentration. This was well documented for
P2X4R using an ultrarapid perfusion system with a resolu-
tion of ~1 ms (17). At the single-channel level, activation
is defined as the transition from the closed to the open state,
desensitization as the transition from the open to the closed-
desensitized state, and deactivation as the transition from the
open to the closed state.
However, the gating of P2X2R and P2X7R (and P2X4R
when bathed in Ca2þ-deficient medium) is more complex,
as these receptors have another gating state, termed dilation
and experimentally defined as the development of conduc-
tivity for NMDGþ during sustained agonist application
(23). P2X7R pore dilation temporally coincides with I2 cur-
rent growth (11), and both I1 and I2 currents were abolished
by application of a P2X7R-specific antagonist, indicating
that I1 and I2 are mediated by the same channel (14). This
is also the case for P2X4R (24). More conclusive evidence
for P2X7R pore dilation, obtained recently, shows that the
receptor pore in the dilated state allows passage of mole-
cules with sizes up to 1.4 nm (12). Whole-cell current re-
cordings also revealed that repetitive stimulation at the
same agonist concentration causes sensitization of P2X7R,
which manifests as a progressive increase in the current
amplitude accompanied by a slower deactivation rate.
Once a steady level of I2 current is reached, responses at
high agonist concentrations are no longer biphasic but
monophasic, indicating a substantial difference in gating
of naı¨ve and sensitized/facilitated receptors (14).
In contrast, pore dilation was not observed in single
P2X7R channel recordings during sustained agonist appli-
cation (21,25), and the reason for this discrepancy is not
clear at this time. Those authors also developed a simple
linear model to describe experimentally observed kinetics
of the short channel openings at negative membrane poten-
tial, with two ATP binding steps at equal binding sites with a
dissociation constant of ~140 mM (21).FIGURE 6 The existence of two phases in cur-
rent growth during sustained stimulation. (A) At
higher agonist concentration (arrows), a cusplike
response at the start of the second phase, I2, was
observed in ~40% of cases, i.e., there was a tran-
sient decay of current before the secondary current
growth was developed. (B) The model also gener-
ates this response when desensitization and recov-
ery rates of the model are made faster, i.e., by
making bH2 ¼ 0:8 s1 and H3 ¼ 1 s1.
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observed in whole-cell current recording at negative poten-
tial, we recently developed an eight-state Markov model that
includes negative cooperativity of agonist binding to naı¨ve
receptors caused by the occupancy of one or two binding
sites; opening of the channel pore to a low conductance state
when two sites are bound; sensitization accompanied by
pore dilation to a high-conductance state when three sites
are occupied; and memory of prior receptor binding, which
accounts for the transition from biphasic gating of naı¨ve re-
ceptor to monophasic gating of sensitized receptor (14). The
eight-state model corresponds to the middle and lower rows
in the scheme shown in Fig. 1. This model is deterministic
and is based on whole-cell recordings but not single-channel
recordings, which do not show dilation or desensitization.
However, P2X2R pore dilation is accompanied by a
decrease, rather than an increase, in the total conductance,
measured as the rate of current rise in a ramp protocol, which
temporally coincides with rapid and partial decay of current
amplitude in clamped cells during sustained agonist stimula-
tion. Both Ca2þ-dependent and Ca2þ-independent steps are
needed to account for the decay in current amplitude (16).
All the above behaviorswere accounted for by a 16-stateMar-
kov kinetic model, extending the eight-state P2X7R model,
that describesATPbinding/unbinding and activation/desensi-
tization. The model assumes that receptors open when two or
three ATP molecules bind and undergo Ca2þ-independent
desensitization, which decreases total conductance despite
pore dilation. The pore dilation can be revealed bymeasuring
a shift in the reversal potential. In calcium-containing media,
receptor desensitization is facilitated. The experiments and
the model together provide a rationale for the lack of sus-
tained current growth in dilating P2X2R. The model also
captures the experimentally observed use-dependent desensi-
tization (i.e., more rapid desensitization during repetitive
stimulation compared to naı¨ve receptors), described by the
Ca2þ-dependent toggle switch (16). Thus, in contrast to other
P2XRs, the rate of decay of P2X2R current during sustained
agonist application does not reflect exclusively the rate of
P2X2R desensitization.
Themain difference betweenP2X2R andP2X7R is in their
dependence on concentration of the native agonist ATP, with
EC50 values of 3 mM and 500 mM, respectively (23,26). To
search for biophysical explanations for P2X7R acting as a
life receptor, we examined the profiles of the P2X7R current
in response to ATP at concentrations below the EC50 values.
Those studies revealed that naı¨ve P2X7Rs not only respond
with monophasic currents but also desensitize slowly, a
feature not reported earlier. This desensitization step was
observed in cells bathed in Ca2þ-deficient medium, as is
also observed in P2X2R desensitization (16). Whereas
P2X2R also exhibits Ca2þ-dependent desensitization, bath
Ca2þ does not facilitate P2X7R desensitization; it rather
acts as an allosteric regulator of P2X7R, causing a rightward
shift in EC50 values for agonists (16). This prompted us toBiophysical Journal 104(12) 2612–2621combine the P2X2R and P2X7R models by adding the upper
row of the P2X2R gating scheme (Fig. 1), which describes
Ca2þ-independent receptor desensitization, to our original
P2X7R gating scheme. This addition did not harm any of
the simulations produced by the original model, and in
someways it improved them, as demonstrated in the Support-
ing Material. In addition, the revised 12-state P2X7R model
successfully simulated Ca2þ-independent desensitization
and offered a visual representation of the status of the open
(Q1þQ2) and dilated (Q3þQ4) states to explain how desen-
sitization is masked at high agonist concentration. The I2
states shown in Fig. 1 represent a conserved core between
P2X2R and P2X7R, but with different transition rates that
make desensitization more apparent in the former and dila-
tion more apparent in the latter.
The calculated amplitudes of the desensitizing currents
were comparable to the amplitudes of isolated desensitizing
currents. Furthermore, the revised model describes the con-
centration dependence of receptor desensitization, which
could not be examined experimentally in WT receptors,
because desensitization was masked by pore dilation at
higher agonist concentrations. Our experiments with two
P2X7R single-residue mutants that do not dilate supported
the model prediction that P2X7R would desensitize at
higher concentrations and with rates higher than those
observed for the WT receptor in response to low agonist
application. The maximum amplitude, Im, generated by
these mutants was only 10–15% of that observed in WT re-
ceptors, further indicating that dilated states provide the ma-
jority of current in the native receptor. Others have also
observed that C-terminal-deleted P2X7R generates low-
amplitude, slow-desensitizing currents (27), probably re-
flecting the lack of pore dilation.
Here, we have not only provided biophysical, mathemat-
ical, and molecular evidence for two P2X7R gating mecha-
nisms, sensitization and desensitization, but have also
shown their different functional roles. P2X7R activation
with desensitization does not harm cells and, upon activa-
tion, receptors are internalized, which has also been
observed by other laboratories (28,29) and for other recep-
tors (30,31). Such small-amplitude desensitizing currents
do not trigger PM blebbing, ER fragmentation, and cell
lysis. Thus, it is reasonable to suggest that such currents pro-
vide cell-life signaling. In contrast, pore dilation provides a
rationale for changes in the PM and ER membrane and cyto-
lytic effects of activated P2X7Rs. The dilated pore leads to
excessive cation influx, accompanied by water influx to
compensate for increased osmotic pressure, and ultimately
cell death. The cytolytic effects could be induced by all con-
centrations of agonists that trigger biphasic response, and
the time needed to reach this stage decreased with an in-
crease in agonist concentration (ranging between 3 and
15 min) and removal of bath Ca2þ, the latter probably re-
flecting increased efficacy of agonists in cells bathed in
Ca2þ-deficient medium (15,21).
Desensitization in P2X7 Receptors 2621In conclusion, our results suggest that occupancy of high-
affinity agonist-binding sites of P2X7R accounts for the
long-lasting effects of these receptors. In contrast, occu-
pancy of low-affinity binding sites leads to cell-death
signaling. Thus, physiological concentrations of exogenous
ATP concentrations could serve as the primary factor in the
action of P2X7R as the cell-life or cell-death receptor.
Because of the extremely high concentrations needed to
trigger cell-death signaling, it is reasonable to suggest that
in most in vivo situations such concentrations would not
be reached and that P2X7R operates like other receptors,
providing controlled Ca2þ influx.SUPPORTING MATERIAL
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